WHO ICTRP trial
The clinical effect of bupivacaine liposome for suprascapular nerve block on…
ChiCTR2500111501 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500111501 |
|---|---|
| Public title | The clinical effect of bupivacaine liposome for suprascapular nerve block on pain relief and functional recovery after arthroscopic capsular release for frozen shoulder: A randomized, double-blind, controlled trial. |
| Scientific title | The clinical effect of bupivacaine liposome for suprascapular nerve block on pain relief and functional recovery after arthroscopic capsular release for frozen shoulder: A randomized, double-blind, controlled trial. |
| Primary sponsor | Affiliated Hospital of Southwest Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Frozen Shoulder |
| Interventions | Bupivacaine liposome group:Liposomal bupivacaine was administered intraoperatively for suprascapular nerve block. ;Ropivacaine group:Ropivacaine was administered intraoperatively for suprascapular nerve block. |
| Registration date | Oct 31, 2025 |
| Target size | Bupivacaine liposome group:15;Ropivacaine group:15 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: